tirzepatide fda update BREAKING NEWS!!! A weight loss drug more effective than Semaglutide has been approved by the today. (Zepbound for weight loss and Mounjaro for diabetes) showed a 15-20.9% weight change in FDA Drug Recalls and Warnings:

While it is rare, some patients on Semaglutide have reported this condition

Mothers who are comparing different GLP-1 medications should weigh this uncertainty as part of their decision, though the practical significance is likely minimal based on current understanding

heart attack, stroke) in adults with type 2 diabetes and heart disease Reduce the risk of kidney decline in adults with type 2 diabetes and chronic kidney disease And Wegovy is FDA-approved to: Reduce excess body weight and manage weight long term in adults and children ages 12+ with obesity as well as adults with obesity or overweight who have at least one weight-related health condition (e.g

The practical consequence: pure telogen effluvium grows back within 12 months

The Link Between GLP-1 Drugs and NAION Recent studies have suggested a potential increased risk of pharmaceutical related NAION associated with GLP-1 medication use